Imperial College London Featured PhD Programmes
Gdansk University of Technology Featured PhD Programmes
Queen’s University Belfast Featured PhD Programmes

breast PhD Projects, Programmes & Scholarships

We have 63 breast PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 63 breast PhD Projects, Programmes & Scholarships

PhD saved successfully

Self Funded PhD project: Biological Evaluation of Ruthenium (II) complexes Targeted against Breast Cancers (BRUT BC)

MCF-7 cells are primary tumour invasive breast ductal carcinoma which have both oestrogen and progesterone receptors. Tumour necrosis factor alpha (TNF alpha) inhibits the growth of MCF-7 breast cancer cells. Read more

Omics approaches to reveal novel players regulating cell signalling in breast cancer

There is an unmet need for novel molecular targeted therapies to improve breast cancer patient survival outcomes. Available therapies for breast cancer patients are based on surgery, radiation, or targeted therapies mostly directed against signalling players, like kinases. Read more

Epi-Genomic and Epi-Transcriptomic Aberrations in Breast Cancer Brain Metastasis

A SFI funded PhD position is available within the Department of Surgery, Royal College of Surgeons, Dublin, Ireland for a highly motivated person with an upper second or first class honours degree or Masters degree in clinical biology or a related subject. Read more

Assessing the molecular mechanisms by which Cathepsin V promotes breast cancer growth and metastasis

Targeted therapies such as tamoxifen, fulvestrant and anastrozole have exhibited significant clinical success since being introduced as treatments for Estrogen Receptor positive (ER+) breast cancer patients. Read more

Development of risk prediction model to raise awareness and aid Breast Cancer Screening In Thailand and SE Asia.

Asia , where epithelial cancers are an emerging and important disease but wide scale population based screening programs cannot yet be justified fully, approaches to rationing entry into screening investigation programs needs to be implemented selectively. Read more

Targeting the ‘Worst of the Worst’ – developing novel treatments for Poor Outcome Triple Negative Breast Cancers.

We will investigate biology driving the aggressive features of Poor Outcome Triple Negative Breast Cancers (PO-TNBCs). PO-TNBCs possess the worst outcomes amongst all breast cancers, with high rates of metastases and chemoresistance. Read more

Filtering Results